Narrow Band Imaging in the Prediction of Surveillance Intervals After Polypectomy in Community Practice: Ready for (a European) Prime Time

July 18, 2014 updated by: Arnaldo Amato, Valduce Hospital

Several reports have suggested that an endoscopic diagnosis of adenoma, by means of narrow band imaging (NBI), might allow the determination of polyp management and surveillance interval, particularly in patients with diminutive polyps (< 5mm), in which the advanced histological features are uncommon and the prevalence of invasive cancer is negligible (1). On this basis, the American Society of Gastrointestinal Endoscopy (ASGE) has set an initiative evaluating the applicability of real-time endoscopic polyp assessment in clinical practice (1), which states that:

  1. for diminutive polyps to be resected and discarded without pathologic assessment, endoscopic technology (when used with high confidence) used to determine histology of polyps < 5mm in size, when combined with the histopathologic assessment of polyps >5 mm in size, should provide a > 90% agreement in assignment of post-polypectomy surveillance intervals when compared to decisions based on pathology assessment of all identified polyps.
  2. In order for a technology to be used to guide the decision to leave suspected rectosigmoid hyperplastic polyps <5 mm in size in place (without resection), the technology should provide > 90% negative predictive value (when used with high confidence) for adenomatous histology

This strategy could potentially exert a significant impact on colonoscopy practice, by decreasing at some extent pathology-associated costs, although those related to histological analysis of >5mm polyps is maintained.

In a recent study performed in our Centre (2), we restricted the application of the resect and discard strategy to patients with small or diminutive polyps only, achieving an accordance between endoscopy-directed and histology-directed surveillance strategy of about 85% in both populations. This approach, where decisions on patient management are driven only by the "in vivo" endoscopic assessment, provides on one hand a slightly lower accordance than the threshold of 90% set by the PIVI, but on the other one it allows the complete spare of pathology related costs, although for a smaller proportion of patients. Moreover we observed a negative predictive value of 86% for the presence of adenoma within the diminutive polyps cohort, although a separate analysis for left sided ones was not performed.

AIms of this single center, prospective, observational study:

  1. To prospectively evaluate the accordance between the endoscopy-directed and histology-directed surveillance strategies by applying the resect and discard strategy for diminutive polyps according to the PIVI statements
  2. To assess the economic impact of the resect and discard strategy when applied either according to the PIVI statements or to restrictedly to subjects with diminutive polyps only
  3. To provide a temporary validation of diagnostic performances of the resect and discard strategy for our group and the potential presence of a learning effect for the methodology
  4. Accordance between endoscopists' and nurses' categorization of adenomas according to standardized criteria (see below)

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

280

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Como, Italy, 22100
        • Ospedale Valduce

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Consecutive adult (18-80 yrs) outpatients undergoing colonoscopy for routine indications (screening, symptoms, surveillance).

Exclusion criteria:

  • patients with CRC history or hereditary polyposis syndromes or hereditary non-polyposis colorectal cancer
  • patients with inadequate bowel preparation
  • patients in which cecal intubation was not achieved or scheduled for partial examinations
  • polyps could not be resected due to ongoing anticoagulation or could not be retrieved for pathologic assessment

Description

Inclusion Criteria:

  • Consecutive adult (18-80 yrs) outpatients undergoing colonoscopy for routine indications (screening, symptoms, surveillance).

Exclusion criteria:

  • patients with CRC history or hereditary polyposis syndromes or hereditary non-polyposis colorectal cancer
  • patients with inadequate bowel preparation
  • patients in which cecal intubation was not achieved or scheduled for partial examinations
  • polyps could not be resected due to ongoing anticoagulation or could not be retrieved for pathologic assessment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
study population

Consecutive adult (18-80 yrs) outpatients undergoing colonoscopy for routine indications (screening, symptoms, surveillance).

Exclusion criteria:

  • patients with CRC history or hereditary polyposis syndromes or hereditary non-polyposis colorectal cancer
  • patients with inadequate bowel preparation
  • patients in which cecal intubation was not achieved or scheduled for partial examinations
  • polyps could not be resected due to ongoing anticoagulation or could not be retrieved for pathologic assessment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
proportion of cases in which the accordance between the endoscopy-directed and histology-directed surveillance strategies by applying the resect and discard strategy for diminutive polyps according to the PIVI statements was observed
Time Frame: 4 months
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (Actual)

February 1, 2014

Study Completion (Actual)

February 1, 2014

Study Registration Dates

First Submitted

July 16, 2014

First Submitted That Met QC Criteria

July 18, 2014

First Posted (Estimate)

July 22, 2014

Study Record Updates

Last Update Posted (Estimate)

July 22, 2014

Last Update Submitted That Met QC Criteria

July 18, 2014

Last Verified

July 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • 5/2014

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Resect and Discard Strategies for Colonoscopy

3
Subscribe